首页> 美国卫生研究院文献>The CRISPR Journal >RNA-Guided Recombinase-Cas9 Fusion Targets Genomic DNA Deletion and Integration
【2h】

RNA-Guided Recombinase-Cas9 Fusion Targets Genomic DNA Deletion and Integration

机译:RNA指导的重组酶-Cas9融合靶向基因组DNA的缺失和整合。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

CRISPR-based technologies have become central to genome engineering. However, CRISPR-based editing strategies are dependent on the repair of DNA breaks via endogenous DNA repair mechanisms, which increases susceptibility to unwanted mutations. Here we complement Cas9 with a recombinase's functionality by fusing a hyperactive mutant resolvase from transposon Tn3, a member of serine recombinases, to a catalytically inactive Cas9, which we term integrase Cas9 (iCas9). We demonstrate iCas9 targets DNA deletion and integration. First, we validate iCas9's function in Saccharomyces cerevisiae using a genome-integrated reporter. Cooperative targeting by CRISPR RNAs at spacings of 22 or 40 bp enables iCas9-mediated recombination. Next, iCas9's ability to target DNA deletion and integration in human HEK293 cells is demonstrated using dual GFP–mCherry fluorescent reporter plasmid systems. Finally, we show that iCas9 is capable of targeting integration into a genomic reporter locus. We envision targeting and design concepts of iCas9 will contribute to genome engineering and synthetic biology.
机译:基于CRISPR的技术已成为基因组工程的核心。然而,基于CRISPR的编辑策略取决于通过内源性DNA修复机制对DNA断裂的修复,从而增加了对有害突变的敏感性。在这里,我们通过将丝氨酸重组酶成员转座子Tn3的高活性突变型分解酶融合到催化失活的Cas9(我们称之为整合Cas9(iCas9))上,使Cas9具有重组酶的功能。我们证明iCas9目标DNA缺失和整合。首先,我们使用基因组整合的报告子验证iCas9在酿酒酵母中的功能。 CRISPR RNA以22或40 bp的间隔进行合作靶向靶向可实现iCas9介导的重组。接下来,使用双重GFP–mCherry荧光报告质粒系统证明了iCas9靶向人HEK293细胞中DNA缺失和整合的能力。最后,我们证明了iCas9能够靶向整合到基因组报告基因座中。我们设想iCas9的靶向和设计概念将有助于基因组工程和合成生物学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号